Skip to content

Evaluation of a Digital Pre-therapy Patient Education Program (StartHjelp) in Outpatient Mental Health Care

Evaluation of a Digital Pre-therapy Patient Education Program (StartHjelp) in Outpatient Mental Health Care

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06212687
Acronym
StartHjelp
Enrollment
170
Registered
2024-01-19
Start date
2024-12-15
Completion date
2030-12-31
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Issue, Mental Disorder, Patient Education

Keywords

Patient education, Patient Satisfaction, Self Efficacy, Pre-therapy, DIgital health, Mental health, Therapy preparation

Brief summary

Community mental health centers (CMHCs) face significant challenges in meeting the needs of individuals with mental health issues. For example, due to high demand, there are long waiting lists and low engagement rates. Innovative interventions are urgently needed to address these challenges to improve patient engagement, coping skills, and overall health outcomes. Educational and self-management interventions have shown promise in enhancing patient activation and treatment satisfaction in other contexts. They may therefore be potential solutions to reduce the identified challenges in the mental health service. To bridge these knowledge and practice gaps, this study aims to evaluate a digital pre-therapy patient education program tailored specifically for adults with mental disorders. This intervention aims to enhance treatment satisfaction, patient activation, knowledge, patient engagement, and overall mental health outcomes.

Detailed description

Community mental health centers (CMHCs) play a pivotal role in the provision of comprehensive care and support for individuals with mental health challenges. However, these centers often face formidable obstacles, including surging patient demands, lengthy waiting lists, high dropout rates, and barriers to engagement, stigma, and negative attitudes. Given these challenges, there exists an urgent imperative to develop innovative interventions that can enhance treatment satisfaction, patient activation, knowledge, and patient engagement, and ultimately yield improved mental health outcomes. One promising approach for addressing these challenges lies in the realm of patient engagement and enablement strategies, particularly through the implementation of digital educational interventions. The investigators hypothesize that utilizing innovative technology to deliver an early digital self-management educational program improves treatment satisfaction, patient activation, knowledge, patient engagement, and overall mental health outcomes without substantially increasing service costs. The impact of utilizing innovative technology to deliver an early digital pre-therapy patient education program through the HelsaMi web patient portal is promising. By leveraging technology, it is possible to reach a wider audience and provide accessible and convenient information, with the same standard to all patients. This approach has the potential to improve patient outcomes, increase treatment adherence, and reduce the burden on healthcare resources. By demonstrating the benefits of digital interventions, our research will pave the way for more efficient and cost-effective mental healthcare services, benefiting both patients and healthcare systems.

Interventions

BEHAVIORALDigital pre-therapy patient education program (StartHjelp)

After randomization the intervention group receives access to a pre-therapy informational app, presenting information about the treatment process, options, patient rights, user organizations, and self-help while on waiting list before mental health outpatient treatment. The information is presented stepwise through video and text, while also providing links to additional information if needed. The videos are made available to the patients gradually, with more general information about the treatment process first, and more specific information as the first session approaches. The patient has the opportunity to rewatch the videos as they please.

After randomization, while on waiting list, the control group gets sent all the same information as the intervention group in written form, by mail.

Sponsors

Norwegian University of Science and Technology
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

The intervention is a pre-therapy informational app, presenting information about the treatment process, options, patient rights, user organizations, and self-help while on waiting list before mental health outpatient treatment. The information is delivered stepwise through video and text, while also providing links to additional information if needed. The videos are made available to the patients gradually, with more general information about the treatment process first, and more specific information as the first session approaches. The patient has the opportunity to rewatch the videos if needed.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Put on the waiting list for mental health outpatient treatment in the active study period. * Willing to participate in the study * Over 18 years * Understand written and spoken Norwegian

Exclusion criteria

* In need of acute help

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfactionmeasured on T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Patient satisfaction with the client satisfaction questionnaire (CSQ). The CSQ prompts the patient to evaluate different aspects of the care received with an 4 point ordinal scale (very dissatisfied, somewhat dissatisfied, somewhat satisfied, very satisfied).
Knowledge and treatment preferencesmeasured on T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks)Knowledge will be measured by five questions. All questions are introduced by how much knowledge do you have about (how outpatient clinics work; what happens in therapy; self management and user participation; patient rights; treatment options available to you). These questions are answered on a six-point ordinal scale ranging from Nothing to Very much. After these 5 questions a follow up question do you know what type of treatment you want?, answered either yes, no, or don't know, is asked. If the answer is yes the patient is prompted to write what it is that they want.
Patient activationmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Patient activation measure 13 will be used. This questionaire measures patient activation by asking about knowledge, skills, and ability to manage one's own health, and health care usage. It consists of 13 items which is answered on an 4 point ordinal scale (Strongly disagree, somewhat disagree, somewhat agree, and strongly agree. Respondents have the option to answer not applicable to me as well.

Secondary

MeasureTime frameDescription
Level of functioningmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Work and social adjustment, or level of functioning, is measured by the Work and Social Adjustment Scale (WSAS). The WSAS have five items that measure functioning across different domains: Work, home management, social leisure activities, private leisure activities, and close relationships. Each question is answered on a 0 to 8 scale, where 0 means not at all impaired, and 8 means very severely impaired.
Patient enablementmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)To measure patient enablement the PEN-13 will be used. The PEN-13 is a 13 item questionnaire which measure patient enablement across two domains (patient practitioner interaction and self management). The answers are given on a five-point Likert scale (strongly disagree, disagree, neither/nor, agree, and strongly agree).
Mental healthmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Mental health will be measured the Patient Health questionnaire 4. A four-item questionnaire with two items measuring the severity of anxiety symptoms and two items measuring the severity of depression symptoms.
Perceived stressmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Perceived stress will be measured by Perceived stress Scale-4, which comprise of four items scored on a five-point ordinal scale scored 0-4. Answers range from Never to very often.
Health related Quality of lifemeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Health related quality of life will be measured with the EQ-5D-5L. This questionnaire measure health related quality of life with five items, where each items prompts the patient to evaluate their problem level across a specific domain (mobility, self-care, usual activities, pain/discomfort and anxiety/depression). Question responses are ordinal and include no problems, slight problems, moderate problems, severe problems and extreme problems. Respondents are also asked to rate their health on a 0-100 scale.
Intentions for patient involvementmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks), T2 (after intervention; up to 8 weeks), T3 (12 months follow up; up to 60 weeks)Intentions for patient involvement were measured by asking the question How much do you want to participate in decisions related to your treatment measured on a six point ordinal scale ranging from nothing to very much.
Expectationsmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks)To investigate patients' expectations about the interventions an open question What are your expectations for this intervention.

Other

MeasureTime frameDescription
App engagementT2 (after intervention; up to 8 weeks)To measure app engagement, anonymized data of app usage will be gathered through the app itself.
Alcohol use disorder testmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks)To screen for alcohol use disorders Alcohol Use Disorders Identification Test (AUDIT) will be used. AUDIT has 10 items and uses the last 12 months as a reference for answering.
Drug use disorder testmeasured on T0 (baseline; at 0 weeks), T1 (after randomization, before intervention; up to 2 weeks)To screen for drug use disorders Drug Use Disorders Identification Test (DUDIT) will be used. DUDIT has 11 items and uses the last 12 months as a reference for answering.
Work statusT4 (24 months follow up; up to 112 weeks)Data from official patient registries will be used to track work status (disability status, employment or sick leave).
System usabilityT2 (after intervention; up to 8 weeks)To test the usability of the app itself the System Usability Scale will be used, a widely used 10-item scale that measure how the user experience using and trying to understand a digital tool.
CostsT4 (24 months follow up; up to 112 weeks)Cost of app development and maintenance are being tracked to compare it against its outcomes to evaluate its cost-benefit.
health care usageT4 (24 months follow up; up to 112 weeks)Data from official patient registries will be used to track (drop out, number of consultations, type of treatment)

Countries

Norway

Contacts

Primary ContactMariela L. Lara-Cabrera, PhD
Mariela.lara@ntnu.no+4748280188
Backup ContactHenrik Pedersen, Cand. Psych.
henrik.pedersen@ntnu.no+4791697343

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026